DAVID HEDRICK

General Manager, C2 CryoBalloon Franchise (April 2025–Present)

• Lead global commercial operations, manufacturing, R&D, and clinical research for the C2 CryoBalloon Franchise, driving portfolio growth and innovation.
• Achieved sales objectives as one of two global divisions, managing full P&L and delivering improvements in profitability and cash flow.
• Developed and implemented strategic plans for market expansion in EMEA, China, Japan, and Australia, aligning with customer needs and market trends.
• Optimized COGS through strategic domestic and international manufacturing solutions, improving gross and operating margins.

• Led the successful relaunch of an FDA-recalled medical device, navigating regulatory challenges to achieve significant sales growth and market re-entry.
• Fostered a culture of continuous improvement, implementing management dashboards to track operational performance.
• Spearheaded FDA clearance for new indications, coordinating R&D, regulatory, and clinical teams for compliant and successful submissions.
• Expanded manufacturing capacity to meet growing sales demands and led upstream/downstream marketing and product management initiatives.
• Responsible for identifying other manufacturing solutions domestically or internationally to lower COGS.
• Worked in matrix management environment managing direct and indirect employees through direct management and influence.
• Established global KOL networks and Centers of Excellence, positioning novel therapies against industry leaders (e.g., Medtronic).
• Developed reimbursement strategies in the UK, Germany, and Belgium through clinical registries and local KOL partnerships.
• Secured approval for Barrett's Esophagus indication in Japan, expanding market access and driving share gain.

• Led U.S. market development during the COVID-19 period, adapting commercial strategies to maintain growth in challenging conditions.

• Member of initial commercial team and responsible for market development in the Southeast, earning President’s Club Awards in 2018 and 2019 for exceptional performance.
• Built regional and national KOL networks, driving adoption of CryoBalloon technology across the Southeast.

• Managed $5M+ annual budget and P&L, driving sales of Cellvizio endomicroscopy technology in a matrixed, multinational environment.
• Increased service contract sales by 200% and raised client acceptance rates from 20% to 60%, creating sustainable revenue streams.
• Boosted national revenues by 25% in 2016 through innovative consignment programs and ASC/fee-per-use models.
• Collaborated with R&D and product management to identify new applications, strengthening market positioning and customer experience.
• Area Sales Manager – Mid-Atlantic Region (2013–2015)
• Achieved #1 ranking in Cellvizio capital equipment sales by targeting surgical and therapeutic applications in community hospitals and specialized practices.
• Exceeded 2015 sales quota by 17% through downstream revenue models and upstream market research.

• Generated $870K in 2013 sales, surpassing quota by $634K, and earned Program Development Manager of the Year Awards in 2012 and 2013.
• Strengthened client relationships across a 13-state territory, driving product commercialization and adoption.

• Selected for prestigious regional sales council, designing and implementing effective sales and training strategies.

President's Club